Multi-omics and Alzheimer’s disease: A slower but surer path to an efficacious therapy?

American Journal of Physiology - Cell Physiology

Volumn 313, Issue 1, 2017, Pages C1-C2

  Pimplikar, Sanjay W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; BIOMICS; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DEMENTIA; EDITORIAL; HUMAN; MEMORY DISORDER; MICROGLIA; MILD COGNITIVE IMPAIRMENT; NERVE CELL; NEUROIMAGING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; BRAIN; GENETICS; GENOMICS; METABOLISM; METABOLOMICS; PROCEDURES; PROTEOMICS; TREATMENT OUTCOME;

ALZHEIMER DISEASE; BRAIN; GENOMICS; HUMANS; METABOLOMICS; PROTEOMICS; TREATMENT OUTCOME;

EID: 85022058586     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00109.2017     Document Type: Editorial

References (7)

1. Karch CM, Cruchaga C, Goate AM. Alzheimer’s disease genetics: from the bench to the clinic. Neuron 83: 11–26, 2014. doi:10.1016/j.neuron.2014.05.041.
2. Mehta D, Jackson R, Paul G, Shi J, Sabbagh M. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015. Expert Opin Investig Drugs 26: 735–739, 2017. doi:10.1080/13543784.2017.1323868.
3. Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH. Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis. J Neurosci 30: 14946–14954, 2010. doi:10.1523/JNEUROSCI.4305-10.2010.
4. Pimplikar SW. Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41: 1261–1268, 2009. doi:10.1016/j.biocel.2008.12.015.
5. Sharma SK. Translational multimodality neuroimaging. Curr Drug Targets 2017. [Epub ahead of print]. doi:10.2174/1389450118666170315111542.
6. Tosto G, Reitz C. Use of “omics” technologies to dissect neurologic disease. Handb Clin Neurol 138: 91–106, 2016. doi:10.1016/B978-0-12-802973-2.00006-9.
7. Zetterberg H. Applying fluid biomarkers to Alzheimer’s disease. Am J Physiol Cell Physiol 2017. [Epub ahead of print]. doi:10.1152/ajpcell.00007.2017.